Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 4, 1996, Pages 437-446

  Kessler, C M ^a   Hirsch, D R ^b   Jacobs, H ^a   MacDougall, R ^b   Goldhaber, S Z ^b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chronic venous insufficiency; fibrinolysis; intermittent pneumatic compression; plasminogen activators

Indexed keywords

11 OXOTHROMBOXANE B2; PROSTACYCLIN; THROMBIN; THROMBOXANE A2 DERIVATIVE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ANTICOAGULATION; ARTICLE; CHRONIC VEIN INSUFFICIENCY; CLINICAL ARTICLE; COMPRESSION THERAPY; FEMALE; FIBRINOLYSIS; HOME CARE; HUMAN; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME;

EID: 0029762458     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199606000-00002     Document Type: Article

References (41)

1. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardham NA. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester Deep Venous Thrombosis Study. Arch Intern Med 1991; 151: 933-938.
2. Strandness DE Jr, Langlois Y, Cramer M, Randlett A, Thiele BL Long-term sequelae of acute venous thrombosis. JAMA 1983; 250: 1289-1292.
3. Lindner DJ, Edwards JM, Phinney ES, Taylor LM, Porter JM. Long-term hemodynamic and clinical sequelae of lower extremity deep vein thrombosis. J Vasc Surg 1986; 4: 436-442.
4. Callam MJ, Harper DR, Dale JJ, Ruckley DV. Chronic leg ulceration: socio-economic aspects. Scot Med J 1988; 33: 358-360.
5. Mayberry JC, Moneta GL, De Frang RD, Porter JM. The influence of elastic compression stockings on deep venous hemodynamics. J Vasc Surg 1991; 13: 91-100.
6. Coleridge-Smith P, Sarin S, Hasty J, Scurr JH. Sequential gradient pneumatic compression enhances venous ulcer healing a randomized trial. Surgery 1990; 108: 871-875.
7. Dillon RS. Treatment of resistant venous stasis ulcers and dermatitis with the end-diastolic pneumatic compression boot. Angiology 1986; 37: 47-56.
8. Ryan TJ. The management of the consequences of chronic venous stasis. Clin Exp Dermatol 1982; 7: 423-428.
9. Hazarika EZ, Wright DE. Chronic leg ulcers: the effect of pneumatic intermittent compression. Practitioner 1981; 225: 189-192.
10. Ginsberg JS, Brill-Edwards P, Kowalchuk G, Hirsh J. Intermittent compression units for the postphlebitic syndrome: a pilot study. Arch Intern Med 1989; 149: 1651-1652.
11. Salzman EW, McManama GP, Shapiro AH, et al. Effect of optimization of hemodynamics on fibrinolytic activity and antithrombotic efficacy of eternal pneumatic calf compression. Ann Surg 1987; 206: 636-641.
12. Nicolaides AN, Niles C, Hoare M, et al. Intermittent sequential pneumatic compression of the legs and thromboembolism-deterrent stockings in the prevention of post-operative deep venous thrombosis. Surgery 1983; 94: 21-25.
13. Nicholas PC, Collins REC, Klein LA, et al. Prevention of deep vein thrombosis in urological patients: a controlled, randomized trial of low-dose heparin and external pneumatic compression boots. Surgery 1978; 83: 230-234.
14. Nicholaides AN, Fernandes JF, Pollack AV. Intermittent sequential pneumatic compression of the legs in the prevention of venous stasis and postoperative deep venous thrombosis. Surgery 1980; 87: 69-76.
15. Clarke-Pearson DL, Synan IS, Hinshaw WM, Coleman RE, Creasman WT. Prevention of venous thromboembolism by external pneumatic compression in patients with gynecologic malignancy. Obstet Gynecol 1984; 63: 92-98.
16. Turpie AGG, Delmore T, Hirsh J, et al. Prevention of venous thrombosis by intermittent sequential calf compression in patients with intracranial disease. Thromb Res 1979; 15: 611-616.
17. Hull R, Delamore TJ, Hirsh J, et al. Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery. Thromb Res 1979; 16: 37-45.
18. Summaria L, Caprini JA, McMillan R, et al. Relationship between postsurgical fibrinolytic parameters and deep vein thrombosis in surgical patients treated with compression devices. American Surgeon 1988; 54: 156-160.
19. Tarney TJ, Rohr PR, Davidson AG. Pneumatic calf compression, fibrinolysis, and the prevention of deep venous thrombosis. Surgery 1980; 88: 489-497.
20. Caprini JA, Chucker JL, Zackerman L, et al. Thrombosis prophylaxis using external compression. Surg Gynecol Obstet 1983; 156: 599-604.
21. Holemans R. Increase in fibrinolytic activity by venous occasion. J Appl Physiol 1963; 18: 1123-1129.
22. Matsumoto M, Narahara N, Andour K, et al. Study on factor VIII related antigen and plasminogen activator released into venous blood from vascular endothelium during tourniquet. II. Study in patients with various thromboembolic diseases. Blood Vessels 1984; 15: 364-367.
23. Weitz J, Michelsen J, Gold K, Owen J, Carpenter D. Effects of intermittent pneumatic calf compression on postoperative thrombin and plasmin activity. Thromb Haemost 1986; 56: 198-201.
24. Guyton DP, Khayat A, Schreiber H, Husni EA. Endogenous plasminogen activator and venous flow: therapeutic implications. Crit Care Med 1987; 15: 122-125.
25. Solen KA, White JV. Correlation between chemical stimulation and filtration flow resistance in human platelet aggregates. Thromb Res 1987; 46: 649-658.
26. Murayama M. Compression inhibits aggregation of human platelets under high hydraulic pressure. Thromb Res 1987; 45: 729-738.
27. Bucknell M. The effect of citrate on euglobulin methods of estimating fibrinolytic activity. J Clin Path 1958; 11: 403-405.
28. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 1985; 57: 1170-1173.
29. Wun TC, Schleuning WD, Reich E. Isolation and characterization of urokinase from human plasma. J Biol Chem 1982; 257: 3276-3283.
30. Jansson JH, Olofsson BO, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. Circulation 1993; 88: 2030-2034.
31. Levin EC, Loskutoff DJ. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol 1982; 94: 631-636.
32. Levin EG, Marze U, Anderson J, et al. Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest 1984; 74: 1988-1995.
33. Dosne AM, Dupuy E, Bodevin E. Production of fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein. Thromb Res 1978; 12: 377-387.
34. Philips M, Juul AG, Thorsen S. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator inhibitor complex. Biochem Biophys Acta 1984; 802: 99-110.
35. 2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci USA 1977; 74: 3922-3926.
36. Marcus AJ, Weksler BB, Jaffee EA. Enzymatic conversion of prostaglandin endoperoxide H2 and arachidonic acid to prostacyclin by cultured human endothelial cells. J Biol Chem 1978; 253: 7138-7141.
37. Frangos JA, Eskin SG, McIntire LV, Ives CL. Flow effects on prostacyclin production by cultured human endothelial cells. Science 1985; 227: 1477-1479.
38. 1 alpha from a lower extremity during external pneumatic compression. Surg Gynecol Obstet 1988; 166: 388-392.
39. 2 (prostacyclin) production by cultured bovine aortic endothelial cells. Circulation 1982; 66: 53-63.
40. Knight MTN, Dawson R. Effect of intermittent compression of the arms on deep venous thrombosis in the legs. Lancet 1976; 2: 1265-1268.
41. Thomas PR, Dormanty JA. White cell and platelet trapping in patients with chronic venous insufficiency. Phlebologie 1988; 41: 771-776.